SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-22-034860
Filing Date
2022-09-27
Accepted
2022-09-27 16:50:06
Documents
4
Period of Report
2022-11-29

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20005397x1_pre14a.htm PRE 14A 246482
2 logo_endra.jpg GRAPHIC 52091
3 ny20005397x1_pc01.jpg GRAPHIC 565974
4 ny20005397x1_pc02.jpg GRAPHIC 625279
  Complete submission text file 0001140361-22-034860.txt   1959134
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37969 | Film No.: 221271687
SIC: 3845 Electromedical & Electrotherapeutic Apparatus